26 May 2013
Keywords: fda, further, delays, psoriasis, drug, stelara, requests
Article | 12 January 2009
The US Food and Drug Administration has announced further delays for US health care major Johnson & Johnson subsidiary Centocor's Stelara
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2009
24 May 2013
© 2013 thepharmaletter.com